Harvard Bioscience Announces Second Quarter 2026 Financial Results

Go back to Harvard Bioscience Announces Second Quarter 2026 Financial Results
Harvard Bioscience, Inc. (NASDAQ: HBIO) Delayed: 8.34 --0 (-0%)
Previous Close $8.34    52 Week High $3.90 
Open $8.34    52 Week Low $2.25 
Day High $8.34    P/E N/A 
Day Low $8.34    EPS $-0.03 
Volume 170